Frequency: Quarterly E- ISSN: Awaited P- ISSN: Abstracted/ Indexed in: Ulrich's International Periodical Directory, Google Scholar, SCIRUS, getCITED, Genamics JournalSeek
Quarterly published in print and online "Inventi Rapid: Oncology (Formerly Inventi Rapid: Cancer)" publishes high quality unpublished as well as high impact pre-published research and reviews catering to the needs of researchers and professionals. This journal focuses on all the aspects of oncology including etiology, course, and treatments of cancer. Aimed at the broader audience the journal accomplishes the objectives by facilitating the transfer of knowledge from the laboratory to the bedside; by contributing to cancer prevention, early detection, diagnosis, cure, and rehabilitation.
In the past few years, a lot of progress has been made in understanding how cancer might develop and how to treat it. Cancer is still hard to treat in the 21st century, though, because the number of people who get it is going up. Radiation therapy, surgery, chemotherapy, immunotherapy and hormonal therapy are all ways to treat cancer. Radiation therapy is still an important part of treating cancer. About half of all cancer patients get radiation therapy at some point during their illness and it makes up about 40% of treatments that cure cancer. The main goal of radiation therapy is to stop cancer cells from dividing and making more cancer cells. In the UK, 2011 has been named the year of radiation therapy to mark a century of progress since Marie Curie won her second Nobel Prize for her work on radium. Over the last 100 years, there have been constant improvements in how radiation is used to treat cancer and scientists have learned more about how cancer cells react to radiation. These improvements will help cancer patients live longer and have fewer side effects from treatment. In this review, we converse about radiation therapy's basic ideas, how it is used and how it has changed over time, as well as its biological effects....
Cervical cancer is common type of cancer that seen in woman now-a-days. Most of woman in developing countries like America, Africa, South and East Asia are prone to this type of cancer. It became the most common reason for death of women. Death happens due to failure to initiate or to go through certain cytology based screening programs. Majorly it causes because of human papilloma virus (HPV). It transmits through sexual contact. By histological studies of tissue isolated by biopsy disease is confirmed. Treatment for increase the life span can be given but complete curing cannot be done. Care should be taken to prevent the disease....
Due to the limited therapeutic index and the intrinsic toxicity of anticancer drugs, drug reactions in oncology are of special concern. Interactions with other drugs could trigger slight differences in the chemotherapy agent's pharmacokinetics or pharmacodynamic, which may dramatically affect its effectiveness or toxicity. Precise data are not available, but the occurrence of drug-drug interactions in oncology is theorized to be higher than in most other conditions. The identification of potentially clinically important drug reactions has been made possible by advances in in-vitro approaches and early clinical research. Typically, cancer patients take a number of medications to manage related conditions, such as pain and nausea. The types of drug interactions that arise in oncology, the pathways causing these interactions and selected examples are illustrated....
Loading....